HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance

Area of Science:

• Polymer Chemistry
• Nanomedicine
• Pharmacology

Background:

• N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer is widely utilized as a nanotherapeutic carrier.
• The role of HPMA in drug delivery extends beyond mere payload carriage.
• HPMA's influence on the molecular mechanisms of antitumor action is significant.

Purpose of the Study:

• To review the mechanisms by which HPMA copolymers enhance the antitumor efficacy of conjugated chemotherapeutic drugs.
• To elucidate the impact of HPMA on the molecular and cellular interactions of drug delivery systems.

Main Methods:

• Literature review focusing on studies investigating HPMA-drug conjugates.
• Analysis of molecular mechanisms including cellular internalization, intracellular trafficking, and drug resistance modulation.
• Examination of effects on drug accumulation, detoxification, repair pathways, and cell death induction.

Main Results:

• HPMA-drug complexes exhibit altered cellular uptake and intracellular trafficking compared to free drugs.
• HPMA influences drug distribution within tumors and tumor cells.
• HPMA conjugates can overcome existing drug resistance and prevent new resistance development.
• HPMA inhibits cellular drug detoxification and repair mechanisms.
• HPMA affects cell death signaling, promoting apoptosis and necrosis.

Conclusions:

• HPMA copolymer significantly enhances the antitumor activity of conjugated chemotherapeutic agents.
• The polymer's influence on cellular processes leads to improved drug delivery and efficacy.
• HPMA-based drug delivery systems offer a promising strategy for overcoming cancer drug resistance and improving treatment outcomes.